These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28956)

  • 21. 3H-Spiroperidol binding to striatal membranes of mutant Han-Wistar rats which exhibit spastic paresis.
    Golombiowska-Nikitin K; Sontag KH; Osborne NN
    Experientia; 1981 May; 37(5):490-1. PubMed ID: 7250319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of stereospecific [3H]spiroperidol binding sites in mammalian lymphocytes.
    Le Fur G; Phan T; Uzan A
    Life Sci; 1980 Apr; 26(14):1139-48. PubMed ID: 7392792
    [No Abstract]   [Full Text] [Related]  

  • 23. Regulation by cations of [3H]spiroperidol binding associated with dopamine receptors of rat brain.
    Usdin TB; Creese I; Snyder SH
    J Neurochem; 1980 Mar; 34(3):669-76. PubMed ID: 6766497
    [No Abstract]   [Full Text] [Related]  

  • 24. Chronic treatments with zotepine, thioridazine, and haloperidol affect apomorphine-elicited stereotypic behavior and striatal 3H-spiroperidol binding sites in the rat.
    Lai H; Carino MA; Horita A
    Psychopharmacology (Berl); 1981; 75(4):388-90. PubMed ID: 6122233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding.
    Leysen JE; Gommeren W; Laduron PM
    Biochem Pharmacol; 1978 Feb; 27(3):307-16. PubMed ID: 23126
    [No Abstract]   [Full Text] [Related]  

  • 26. Anomalous properties of [3H]spiperone binding sites in various areas of the rat limbic system.
    Howlett DR; Morris H; Nahorski SR
    Mol Pharmacol; 1979 May; 15(3):506-14. PubMed ID: 492143
    [No Abstract]   [Full Text] [Related]  

  • 27. Enhanced [3H]spiroperidol binding in striatum of spontaneously hypertensive rat (SHR).
    Chiu P; Rajakumar G; Chiu S; Kwan CY; Mishra RK
    Eur J Pharmacol; 1982 Aug; 82(3-4):243-4. PubMed ID: 7128691
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of melanotropin release inhibiting factor, its metabolites and analogs on [3H]spiroperidol and [3H]apomorphine binding sites.
    Bhargava HN
    Gen Pharmacol; 1983; 14(6):609-14. PubMed ID: 6141122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation by cholecystokinins of 3H-spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sites.
    Fuxe K; Agnati LF; Benfenati F; Cimmino M; Algeri S; Hökfelt T; Mutt V
    Acta Physiol Scand; 1981 Dec; 113(4):567-9. PubMed ID: 6291324
    [No Abstract]   [Full Text] [Related]  

  • 30. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic phencyclidine, like amphetamine, produces a decrease in [3H]spiroperidol binding in rat striatum.
    Robertson HA
    Eur J Pharmacol; 1982 Mar; 78(3):363-5. PubMed ID: 7067731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solubilization and characterization of [3H]spiroperidol binding sites from subcellular fractions of the calf striatum.
    Clement-Cormier YC; Kendrick PE
    Biochem Pharmacol; 1980 Mar; 29(6):897-903. PubMed ID: 7387707
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of cholecystokinin octapeptide on rat striatal 3H spiperone binding.
    O'Shaughnessy C; Poat JA; Turnbull MJ
    Biochem Pharmacol; 1985 Aug; 34(15):2675-7. PubMed ID: 4015708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopaminergic component of [3H]spiroperidol binding in the rat anterior cerebral cortex.
    Marchais D; Tassin JP; Bockaert J
    Brain Res; 1980 Feb; 183(1):235-40. PubMed ID: 7357406
    [No Abstract]   [Full Text] [Related]  

  • 35. Cataleptogenic doses of morphine suppress 3H-spiroperidol binding to striatal membranes.
    Golembiowska-Nikitin K; Pilc A; Vetulani J
    Naunyn Schmiedebergs Arch Pharmacol; 1982 May; 319(2):140-1. PubMed ID: 7202125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic treatment with metoclopramide induces behavioral supersensitivity to apomorphine and enhances specific binding of 3H-spiroperidol to rat striata.
    Lautin A; Wazer D; Stanley M; Rotorsen J; Gershon S
    Life Sci; 1980 Jul; 27(4):305-16. PubMed ID: 7412477
    [No Abstract]   [Full Text] [Related]  

  • 37. Competitive inhibition of [3H]spiperone binding to D-2 dopamine receptors in striatal homogenates by organic calcium channel antagonists and polyvalent cations.
    De Vries DJ; Beart PM
    Eur J Pharmacol; 1984 Oct; 106(1):133-9. PubMed ID: 6241565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA; Altar CA; Wong CA; Marshall JF
    Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [3H]spiperone binding sites in rat primary glial cultures, C6 glioma, and B104 neuroblastoma.
    Severson JA; de Vellis JS; Finch CE
    J Neurosci Res; 1983; 9(1):21-6. PubMed ID: 6834436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional distinction between DA-stimulated adenylate cyclase and 3H-spiperone binding sites in rat striatum.
    Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
    Eur J Pharmacol; 1979 Oct; 58(3):341-2. PubMed ID: 510367
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.